Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hurthle cell tumor

H Y Chen1, L B Benjamin, M F Chen

  • 1Department of General Surgery, Chang Gung Memorial Hospital, Keelung, Taiwan, ROC.

International Surgery
|April 1, 1996
PubMed
Summary
This summary is machine-generated.

Hurthle cell tumors are rare thyroid conditions. While carcinoma patients tend to be older with larger tumors, pathological diagnosis is key. Surgical management differs for adenoma versus carcinoma.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

GW170104: Observation of a 50-Solar-Mass Binary Black Hole Coalescence at Redshift 0.2.

Physical review letters·2017
Same author

Observation of ψ(3686)→e^{+}e^{-}χ_{cJ} and χ_{cJ}→e^{+}e^{-}J/ψ.

Physical review letters·2017
Same author

Upper Limits on the Stochastic Gravitational-Wave Background from Advanced LIGO's First Observing Run.

Physical review letters·2017
Same author

Directional Limits on Persistent Gravitational Waves from Advanced LIGO's First Observing Run.

Physical review letters·2017
Same author

Cardiovascular disease in rheumatoid arthritis: medications and risk factors in China.

Clinical rheumatology·2017
Same author

Prospects for Observing and Localizing Gravitational-Wave Transients with Advanced LIGO and Advanced Virgo.

Living reviews in relativity·2017
Same journal

The histopathologic effects of L-carnitine in Sodium Taurocholate Induced Severe Pancreatitis Model.

International surgery·2016
Same journal

DOES NEUTROPHIL TO LYMPHOCYTE RATIO PREDICT HOSPITAL STAY IN APPENDECTOMY PATIENTS?

International surgery·2016
Same journal

Proliferation, Apoptosis and Invasion effects of mistletoe alkali on human osteosarcoma U2OS in vitro.

International surgery·2016
Same journal

Severe Irreversible Diastasis Recti Abdominis and Abdominal Hernia in Postpartum Women: Rare Case Report.

International surgery·2016
Same journal

Mesothelial Cysts of the Round Ligament of the Uterus in 9 Patients: a 15-year experience.

International surgery·2016
Same journal

Successful Conservative Management of a Retroperitoneal Abscess with a Sinus to the Colon: A Case Report.

International surgery·2016
See all related articles

Area of Science:

  • Endocrinology
  • Oncology
  • Pathology

Background:

  • Hurthle cell tumors are rare thyroid neoplasms.
  • Recent literature lacks comprehensive management guidelines.
  • This study reviews a historical patient cohort.

Purpose of the Study:

  • To analyze clinical characteristics and outcomes of Hurthle cell tumors.
  • To evaluate management strategies for Hurthle cell adenoma and carcinoma.
  • To identify factors differentiating benign from malignant Hurthle cell tumors.

Main Methods:

  • Retrospective review of 26 patients with pathologically confirmed Hurthle cell tumors (1988-1994).
  • Analysis of patient demographics, tumor size, clinical presentation, and treatment outcomes.
  • Pathological examination for capsular and vascular invasion.

Related Experiment Videos

Main Results:

  • 22 adenomas and 4 carcinomas identified; predominantly female patients.
  • Carcinoma patients were older (mean 49.5 vs 45.1 years) with larger tumors (3.7 vs 2.3 cm).
  • Pathological diagnosis with capsular/vascular invasion accurately differentiated benign from malignant tumors.

Conclusions:

  • Hurthle cell tumors show female predominance; carcinoma patients may be older with larger tumors.
  • Lobectomy is suitable for adenoma; total thyroidectomy for carcinoma.
  • Long-term follow-up is essential for all patients.